|
|
||||||||
|

FIGURE 3. (A) No correlation was found between Gleason sum and 18F-FDG uptake (P = 0.42). Patients with advanced-stage disease showed higher 18F-FDG uptake than did those with earlier stages (P = 0.03). Weak correlation was found between 18F-FDG and serum PSA value (r = 0.71). (B) No correlation was found among clinical parameters and 11C-acetate uptake. Gl = Gleason sum.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |